Drug manufacturers seek to combat Medicare negotiations at Supreme Court
On February 26, 2019, the Chief Executive Officers (CEOs) of prominent pharmaceutical companies appeared before the Senate Finance Committee in Washington, DC for a hearing on “Drug Pricing in America: A Prescription for Change, Part II.” The CEOs in attendance included Richard A. Gonzalez of AbbVie Inc, Pascal Soriot of AstraZeneca, Giovanni Caforio of Bristol-Myers …